Hiv-infected Current Events | Hiv-infected News | 6
|
| Page
6 of
55 |
1089 Results |
|
|
|
Sort By:
Page Views | Date |
Malaria may fuel spread of HIV in sub-Saharan Africa
Malaria may be fueling the spread of HIV in areas of sub-Saharan Africa where there is a substantial overlap between the two diseases, while HIV may be playing a role in boosting adult malaria-infection rates in some parts of the region, according to a new study by researchers at Fred Hutchinson Cancer Research Center and the University of... view more... (2006-12-08)
The Role Of Sexually Transmitted Diseases, Malaria, And Tuberculosis On The Hiv-1/Aids Epidemic In Africa (p 2177)
The effect of HIV-1 on other infectious diseases in Africa is an increasing public health concern. In a review in this week's issue of THE LANCET, Elizabeth Corbett from the London School of Hygiene and Tropical Medicine, UK, and the Harare Biomedical Research and Training Institute, Zimbabwe, and colleagues describe the role that three major... view more... (2002-06-19)
HIV handicaps itself to escape immune system pressure
People with the ability to stave off AIDS for years after initial infection by HIV have been called "long-term non-progressors" or "elite controllers." view more (2009-04-16)
Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. view more (2009-01-06)
EARLY ASSESSMENT PREDICTS LONG-TERM EFFICACY OF HIV-1 ANTIRETROVIRAL THERAPY (p 1760)
A study in this week's issue of THE LANCET highlights how very early (one week) assessment can reliably predict the long-term effectiveness of antiretroviral therapy for HIV-1. Early assessment of antiretroviral drug efficacy is important for the prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective and toxic... view more... (2001-11-21)
ACP recommends routine HIV screening for all patients
On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.org. view more (2008-12-01)
The release of new data from the HVTN 502 HIV vaccine study
The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were more HIV infections in the vaccinees as compared... view more... (2007-11-08)
Highly active antiretroviral therapy of similar benefit for HIV-infected injection drug users
Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART. view more (2008-08-04)
European research yields guidelines for treatment of HIV-positive pregnant women and infants
New guidelines for the treatment of HIV-positive women and children are emerging from European research. The guidelines, aimed at reducing mother-to-child transmission of HIV, are to be published on 28 June 2002 as a supplement to the journal AIDS. A comparable set of guidelines for paediatric patients will be published in July 2002. Both reports... view more... (2002-06-28)
Novel method to create personalized immunotherapy treatments
Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos'process for developing dendritic cell-based immunotherapies for HIV. view more (2008-08-06)
Substantial Increase In Survival After Introduction Of Highly Active Antiretroviral Therapy For HIV-1 Infection (p 1267)
Research published in this week's issue of THE LANCET highlights the substantial increased survival for people with HIV-1 since the introduction of highly active antiretroviral therapy (HAART) in 1997. However the study also shows a shift in risk profiles compared with earlier data-people over 45 years no longer appear to have reduced survival... view more... (2003-10-15)
HIV in the nervous system - still a cause for concern?
HIV infection can be controlled with antiretroviral drugs, but it cannot be wiped out. New evidence suggests that low levels of HIV may still lead to long-term brain damage and dementia, scientists heard today (Tuesday 09 April 2002) at the spring meeting of the Society for General Microbiology at the University of Warwick. "There is concern for... view more... (2002-04-02)
To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says
The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population. view more (2006-11-10)
INCREASED RISK OF TUBERCULOSIS RECURRENCE IN PEOPLE WITH HIV-1 INFECTION (pp 1470, 1488)
People with HIV-1 infection are at an increased risk of recurrent tuberculosis, and could benefit from preventative treatment after the first episode of the disease, concludes research published in this week's issue of THE LANCET. Patients with HIV-1 infection respond well to treatment for active tuberculosis, but whether such patients are at... view more... (2000-10-25)
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. view more (2009-02-10)
Early-stage immune system control of HIV may depend on inherited factors
How well an individual's immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells. view more (2006-11-06)
Widely used hepatitis B drug spurs HIV drug resistance
A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. view more (2007-03-01)
Researchers seek to solve mystery of natural HIV control
An international, multi-institutional research consortium is seeking to discover how a few HIV-infected individuals are naturally able to suppress replication of the virus. view more (2006-08-17)
Early cessation of breastfeeding by HIV+ women in poor countries and child survival
A new study by researchers from Columbia University's Mailman School of Public Health addresses one of the most challenging issues in infant health and preventing mother-to-child HIV transmission in poor countries. view more (2008-07-25)
Virological evidence cannot prove transmission in HIV criminal cases
Virological evidence cannot prove transmission in HIV criminal cases, warn experts in this week's BMJ. view more (2007-09-07)
|
|
| Page
6 of
55 |
1089 Results |
|
|
|
Sort By:
Page Views | Date |
|
